Four health programs successfully fight the opioid epidemic January 01, 2018By Tracey WalkerShocking opioid overdose statistics make it crucial to address the epidemic. Here are four programs to watch
In this issue
Four PBM programs poised to rein in the opioid epidemic January 01, 2018By Tracey WalkerPBMs are in a unique position to help curb opioid abuse. Here are four programs that demonstrate promising outcomes. How health execs can partner with pharmacists to address opioids January 16, 2018By Tracey WalkerDirector of medication safety and quality for the American Society of Health-System Pharmacists shares how providers can better work with pharmacists to address the opioid epidemic. Autoimmune drug pipeline highlightsMore targeted therapies for autoimmune diseases are on the horizon. Here’s what to anticipate in 2018. Four therapeutic areas to watch in 2018 December 13, 2017By Mari EdlinPrepare for major pipeline developments in diabetes, autoimmune disorders, oncology, and COPD. End-of-life care planning advancements: What health execs should know January 04, 2018By Bob KronemyerMore awareness and new state laws regarding end-of-life treatment are affecting treatment approaches. Here’s what you need to know. Eight ways doctors can address the opioid epidemic January 05, 2018By Karen AppoldAs the opioid epidemic rages, doctors and hospitals should consider these tips and strategies employed by other organizations. Will biosimilars deliver on expectations? January 06, 2018By Bryant FurlowThis might be the year when it becomes clear, perhaps painfully so, whether or not biosimilars can deliver on cost savings expectations. The top three pharmacy challenges of 2018 January 07, 2018By Mari EdlinFind out what challenges top the list, and what analysts say can be done about them. Top 10 challenges for healthcare executives in 2018 January 08, 2018By Aubrey WestgateManaged Healthcare Executive board members identify top challenges. How does your list compare?